Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 1.09% is 99% below its 5-year average of 86.37%, near the low end of its 5-year range (1.09%–235.39%).
As of the fiscal period ended Saturday, July 4, 2026. 92.32% below its 12-month average of 14.24%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
RETURN ON EQUITY (ROE)
1.09%
RETURN ON EQUITY (ROE) AVG TTM
14.24%
RETURN ON EQUITY (ROE) AVG 3Y
33.97%
RETURN ON EQUITY (ROE) AVG 5Y
86.37%
RETURN ON EQUITY (ROE) AVG 10Y
79.57%
RETURN ON EQUITY (ROE) AVG 15Y
32.34%
RETURN ON EQUITY (ROE) AVG 20Y
35.89%
CURRENT VS TTM AVG
-92.32%
CURRENT VS 3Y AVG
-96.78%
CURRENT VS 5Y AVG
-98.73%
CURRENT VS 10Y AVG
-98.63%
CURRENT VS 15Y AVG
-96.62%
CURRENT VS 20Y AVG
-96.95%
SECTOR MEDIAN · HEALTHCARE
13.25%
median of 83 covered companies
CURRENT VS SECTOR MEDIAN
-91.75%
vs the sector median at left
Waters Corporation
Market Cap
$30.13B
Return on Equity (ROE)
1.09%
TTM Avg
14.24%
3Y Avg
33.97%
5Y Avg
86.37%
Market Cap
$30.16B
Return on Equity (ROE)
14.51%
TTM Avg
21.84%
3Y Avg
21.53%
5Y Avg
32.27%
Market Cap
$30.86B
Return on Equity (ROE)
83.10%
TTM Avg
66.19%
3Y Avg
56.82%
5Y Avg
52.60%
Market Cap
$29.33B
Return on Equity (ROE)
5.97%
TTM Avg
9.02%
3Y Avg
4.86%
5Y Avg
4.86%
Market Cap
$31.40B
Return on Equity (ROE)
4.43%
TTM Avg
8.42%
3Y Avg
11.86%
5Y Avg
16.52%
Market Cap
$31.90B
Return on Equity (ROE)
38.14%
TTM Avg
28.93%
3Y Avg
25.01%
5Y Avg
22.95%
Market Cap
$31.90B
Return on Equity (ROE)
-22.60%
TTM Avg
-10.46%
3Y Avg
-1.37%
5Y Avg
1.10%
Market Cap
$32.06B
Return on Equity (ROE)
23.13%
TTM Avg
23.30%
3Y Avg
22.33%
5Y Avg
21.49%
Market Cap
$26.79B
Return on Equity (ROE)
7062.40%
TTM Avg
-2178.82%
3Y Avg
-341.14%
5Y Avg
-117.12%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $30.13B | 1.09% | 14.24% | 33.97% | 86.37% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.16B | 14.51% | 21.84% | 21.53% | 32.27% |
| Zoetis Inc. (ZTS)vs › | $30.86B | 83.10% | 66.19% | 56.82% | 52.60% |
| Medline Inc. (MDLN)vs › | $29.33B | 5.97% | 9.02% | 4.86% | 4.86% |
| Biogen Inc. (BIIB)vs › | $31.40B | 4.43% | 8.42% | 11.86% | 16.52% |
| DexCom, Inc. (DXCM)vs › | $31.90B | 38.14% | 28.93% | 25.01% | 22.95% |
| Centene Corp. (CNC)vs › | $31.90B | -22.60% | -10.46% | -1.37% | 1.10% |
| ResMed Inc. (RMD)vs › | $32.06B | 23.13% | 23.30% | 22.33% | 21.49% |
| Mettler-Toledo International Inc. (MTD)vs › | $26.79B | 7062.40% | -2178.82% | -341.14% | -117.12% |
| Labcorp Holdings Inc. (LH)vs › | $26.64B | 11.65% | 9.71% | 9.35% | 12.84% |
ROE
1.1%
ROA
0.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-07-04 | 1.09% |
| 2026-04-04 | 2.94% |
| 2025-12-31 | 25.09% |
| 2025-09-27 | 27.84% |
| 2025-06-28 | 30.62% |
| 2025-03-29 | 33.48% |
| 2024-12-31 | 34.88% |
| 2024-09-28 | 38.84% |
| 2024-06-29 | 42.19% |
| 2024-03-30 | 48.03% |
| 2023-12-31 | 55.83% |
| 2023-09-30 | 72.12% |
| 2023-07-01 | 87.46% |
| 2023-04-01 | 114.84% |
| 2022-12-31 | 140.29% |
| 2022-10-01 | 180.91% |
| 2022-07-02 | 179.06% |
| 2022-04-02 | 187.91% |
| 2021-12-31 | 188.50% |
| 2021-10-02 | 235.39% |
| 2021-07-03 | 246.20% |
| 2021-04-03 | 266.77% |
| 2020-12-31 | 224.68% |
| 2019-09-28 | 499.29% |
| 2019-06-29 | 104.19% |
| 2019-03-30 | 61.05% |
| 2018-12-31 | 37.89% |
| 2018-09-29 | 2.96% |
| 2018-06-30 | 2.56% |
| 2018-03-31 | 1.26% |
| 2017-12-31 | 0.91% |
| 2017-09-30 | 20.84% |
| 2017-07-01 | 21.31% |
| 2017-04-01 | 22.26% |
| 2016-12-31 | 22.65% |
| 2016-10-01 | 22.05% |
| 2016-07-02 | 22.78% |
| 2016-04-02 | 22.22% |
| 2015-12-31 | 22.78% |
| 2015-10-03 | 23.84% |
| 2015-07-04 | 24.14% |
| 2015-04-04 | 24.56% |
| 2014-12-31 | 22.78% |
| 2014-09-27 | 22.91% |
| 2014-06-28 | 22.05% |
| 2014-03-29 | 21.94% |
| 2013-12-31 | 25.52% |
| 2013-09-28 | 29.92% |
| 2013-06-29 | 31.93% |
| 2013-03-30 | 33.45% |
| 2012-12-31 | 31.45% |
| 2012-09-29 | 31.78% |
| 2012-06-30 | 33.64% |
| 2012-03-31 | 33.18% |
| 2011-12-31 | 35.30% |
| 2011-10-01 | 36.44% |
| 2011-07-02 | 33.94% |
| 2011-04-02 | 34.82% |
| 2010-12-31 | 35.72% |
| 2010-10-02 | 38.91% |
| 2010-07-03 | 41.88% |
| 2010-04-03 | 40.03% |
| 2009-12-31 | 38.08% |
| 2009-10-03 | 40.80% |
| 2009-07-04 | 42.98% |
| 2009-04-04 | 49.17% |
| 2008-12-31 | 48.79% |
| 2008-09-27 | 49.93% |
| 2008-06-28 | 46.70% |
| 2008-03-29 | 45.48% |
| 2007-12-31 | 45.74% |
| 2007-09-29 | 54.65% |
| 2007-06-30 | 64.99% |
| 2007-03-31 | 62.43% |
| 2006-12-31 | 61.32% |
| 2006-09-30 | 83.36% |
| 2006-07-01 | 77.12% |
| 2006-04-01 | 76.92% |
| 2005-12-31 | 71.21% |
| 2005-10-01 | 55.80% |
| 2005-07-02 | 43.17% |
| 2005-04-02 | 39.72% |
| 2004-12-31 | 33.01% |
| 2004-10-02 | 33.28% |
| 2004-07-03 | 35.41% |
| 2004-04-03 | 31.02% |
| 2003-12-31 | 28.94% |
| 2003-09-30 | 27.04% |
| 2003-06-30 | 25.67% |
